Eva Wex
Impact in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Inhalation and Respiratory Drug Delivery
-
- Sarcoidosis and Beryllium Toxicity Research
- Asthma and respiratory diseases
Papers in
-
- Asthma and respiratory diseases 6
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
- Respiratory and Cough-Related Research 2
- Pulmonary Hypertension Research and Treatments 1
- Co-authors
- Lutz Wollin (4 shared papers)Susanne Stowasser (1 shared paper)Katrin Hostettler (1 shared paper)Martin Kolb (1 shared paper)Alexander Pautsch (1 shared paper)Gisela Schnapp (1 shared paper)Florian Gantner (3 shared papers)Paola Casarosa (1 shared paper)
- Journals
- British Journal of Pharmacology (2 papers)PLoS ONE (2 papers)European Journal of Immunology (1 paper)Molecular Immunology (1 paper)European Respiratory Journal (1 paper)
- Partner nations
- GermanyAustriaSwitzerland
In The Last Decade
Eva Wex
10 papers receiving 927 citations
Eva Wex's Hit Papers
Peers
Comparison fields: 5 of 81
- Pulmonary and Respiratory Medicine 601
- Physiology 163
- Immunology 107
- Immunology and Allergy 29
- Rheumatology 66
Countries citing papers authored by Eva Wex
This map shows the geographic impact of Eva Wex's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Wex with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Wex more than expected).
Fields of papers citing papers by Eva Wex
This network shows the impact of papers produced by Eva Wex. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Wex. The network helps show where Eva Wex may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Wex, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis Hit paper breakdown → | 2015 | 728 |
| 2 | 2013 | 80 | |
| 3 | 2010 | 30 | |
| 4 | 2011 | 25 | |
| 5 | 2015 | 22 | |
| 6 | 2017 | 18 | |
| 7 | 2015 | 16 | |
| 8 | 2014 | 14 | |
| 9 | 2015 | 10 | |
| 10 | 2016 | 1 |
About Eva Wex
Eva Wex is a scholar working on Physiology, Pulmonary and Respiratory Medicine, Genetics, Sensory Systems and Immunology, having authored 10 papers that have together received 944 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (6 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers), Ion Channels and Receptors (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Mast cells and histamine (2 papers), Respiratory and Cough-Related Research (2 papers), Allergic Rhinitis and Sensitization (1 paper) and Pulmonary Hypertension Research and Treatments (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (601 citations), Physiology (163 citations), Immunology (107 citations), Immunology and Allergy (29 citations) and Rheumatology (66 citations). Eva Wex has collaborated with scholars based in Germany, Austria and Switzerland. Frequent co-authors include Lutz Wollin, Susanne Stowasser, Katrin Hostettler, Martin Kolb, Alexander Pautsch, Gisela Schnapp, Florian Gantner, Paola Casarosa, Michael Pieper and Andreas Schnapp. Their work appears in journals such as British Journal of Pharmacology, PLoS ONE, European Journal of Immunology, Molecular Immunology and European Respiratory Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.